United Kingdom

People: AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

13 Sep 2019
Change (% chg)

$-1.22 (-1.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Collis, Steven 

Mr. Steven H. Collis is Chairman of the Board, President, Chief Executive Officer of the Company. He has been a member of our Board since 2011 and has served as our Board's Chairman since March 2016. From November 2010 to July 2011, Mr. Collis served as President and Chief Operating Officer of AmerisourceBergen Corporation. He served as Executive Vice President and President of AmerisourceBergen Drug Corporation from September 2009 to November 2010, as Executive Vice President and President of AmerisourceBergen Specialty Group from September 2007 to September 2009 and as Senior Vice President of AmerisourceBergen Corporation and President of AmerisourceBergen Specialty Group from August 2001 to September 2007. Mr. Collis has held a variety of other positions with AmerisourceBergen Corporation and its predecessors since 1994. Mr. Collis is a member of the Board of the International Federation of Pharmaceutical Wholesalers, Inc. and CEOs Against Cancer (PA Chapter), and is a member of the American Red Cross Board of Governors. He previously served as a Member of the Board of Thoratec Corporation from 2008 to 2015.

Basic Compensation

Total Annual Compensation, USD 3,290,730
Restricted Stock Award, USD 5,599,990
Long-Term Incentive Plans, USD --
All Other, USD 2,623,390
Fiscal Year Total, USD 11,514,100

Options Compensation

  Quantity Market Value
Exercisable 332,351 4,958,760.00
Unexercisable 161,250 1,396,840.00
Exercised 180,000 8,718,890.00
Name Fiscal Year Total

Steven Collis


James Cleary


Silvana Battaglia


Gina Clark


Dale Danilewitz


John Chou

As Of  30 Sep 2018